Physical activity and nonalcoholic fatty liver disease: a roundtable statement from the American College of Sports Medicine.
Stine, Jonathan G ; Long, Michelle T ; Corey, Kathleen E ; Sallis, Robert E ; Allen, Alina M ; Armstrong, Matthew J ; Conroy, David E ; Cuthbertson, Daniel J ; Duarte-Rojo, Andres ; Hallsworth, Kate ... show 9 more
Stine, Jonathan G
Long, Michelle T
Corey, Kathleen E
Sallis, Robert E
Allen, Alina M
Armstrong, Matthew J
Conroy, David E
Cuthbertson, Daniel J
Duarte-Rojo, Andres
Hallsworth, Kate
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2023-05-01
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Although physical activity (PA) is crucial in the prevention and clinical management of nonalcoholic fatty liver disease (NAFLD), most individuals with this chronic disease are inactive and do not achieve recommended amounts of PA. There is a robust and consistent body of evidence highlighting the benefit of participating in regular PA, including a reduction in liver fat and improvement in body composition, cardiorespiratory fitness, vascular biology and health-related quality of life. Importantly, the benefits of regular PA can be seen without clinically significant weight loss. At least 150 minutes of moderate or 75 minutes of vigorous intensity PA are recommended weekly for all patients with NAFLD, including those with compensated cirrhosis. If a formal exercise training program is prescribed, aerobic exercise with the addition of resistance training is preferred. In this roundtable document, the benefits of PA are discussed, along with recommendations for 1) PA assessment and screening; 2) how best to advise, counsel and prescribe regular PA and 3) when to refer to an exercise specialist.
Citation
Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, Conroy DE, Cuthbertson DJ, Duarte-Rojo A, Hallsworth K, Hickman IJ, Kappus MR, Keating SE, Pugh CJA, Rotman Y, Simon TL, Vilar-Gomez E, Wong VW, Schmitz KH. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2023 May 1. doi: 10.1249/MSS.0000000000003199. Epub ahead of print.
Type
Article